Abnormalities in body composition and nutritional status in HIV-infected children and adolescents on antiretroviral therapy

International Journal of STD and AIDS

Volumn 22, Issue 8, 2011, Pages 453-456

  de Barros Ramalho, L C ^a   Goncalves E M ^a   de Carvalho, W R G ^a   Guerra Junior, G ^a   Centeville, M ^a   Aoki, F H ^a   Morcillo, A M ^a   dos Santos Vilela, M M ^a   da Silva, M T N ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antiretroviral therapy; Body composition; Children and adolescents; HIV; Nutritional status

Indexed keywords

PROTEINASE INHIBITOR;

ABNORMAL BODY BUILD; ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CHILD; CHILD GROWTH; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK; SCHOOL CHILD; SEX DIFFERENCE; SIDE EFFECT; STUNTING; WAIST HIP RATIO;

ADOLESCENT; ANTI-HIV AGENTS; BODY COMPOSITION; CASE-CONTROL STUDIES; CHILD; CHILD NUTRITION DISORDERS; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH DISORDERS; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INFANT; MALE; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; ODDS RATIO; REGRESSION ANALYSIS;

EID: 79960984980     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.010516     Document Type: Article

References (36)

1. Brazil. Ministry of Health, Secretary of Health Surveillance, National Program on Sexually Transmitted Diseases and AIDS. Recommendations for Antiretroviral Therapy in HIV - Infected Children and Adolescents: Pocket Handbook. Brasília: Ministry of Health, 2009. Portuguese
2. Leandro-Merhi VA, Vilela MMS, da Silva MTN, et al. Evolution of nutritional status of infants infected with the human immunodeficiency virus. Sao Paulo Med J 2000;118:148-53.
3. The European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. The European Collaborative Study. Pediatrics 2003;111:52-60.
4. Brady MT, Oleske JM, Williams PL, et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr 2010;53:86-94.
5. Palladino C, Bellón JM, Jarrín I, et al. Impact of highly active antiretroviral therapy (HAART) on AIDS and death in a cohort of vertically HIV type 1-infected children: 1980-2006. AIDS Res Hum Retroviruses 2009;25:1091-7.
6. Hacker MA, Kaida A, Hogg RS, Bastos FI. The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006. Cad Saúde Públic 2007;23:345-59.
7. Anuurad E, Semrad A, Berglund L. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord 2009;7:401-10.
8. McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS 2004;18:1753-68.
9. Florindo AA, de Oliveira Latorre Mdo R, Jaime PC, Segurado AA. Leisure time physical activity prevents accumulation of central fat in HIV/AIDS subjects on highly active antiretroviral therapy. Int J STD AIDS 2007;18:692-6.
10. Samaras K, Wand H, Law M, et al. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism. Curr HIV Res 2009;7:454-61.
11. Souza DT, Rondó PH, Reis LC. The nutritional status of children and adolescents with HIV/AIDS on antiretroviral therapy. J Trop Pediatr 2010;0:1-4.
12. Center for Disease Control. Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age MMWR. CDC 1994;43:1-10.
13. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign: Human Kinetics, 1988.
14. National Center for Health Statistics. 2000 CDC Growth Charts for the United States: Methods and Development. Series Report 11, 246. Washington, 2000. p. 201.
15. Cole TJ, Flegal KM, Nicholls D, et al. Body mass index cut offs to define thinness in children and adolescents: international survey. BMJ 2007;335:194-9.
16. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child Survey overweight and obesity worldwide: international. BMJ 2000;320:1240-3.
17. Slaughter MH, Lohman TG, Boileau RA, et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol 1988;60:709-23.
18. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
19. Carr A, Emery S, Law M, et al. HIV Lipodystrophy Case Definition Study Group. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003;361:726-35.
20. Matsudo S, Araujo T, Matsudo V, et al. Questiona ́rio Internacional de Atividade Fi{dotless} ́sica (IPAQ): estudo de reprodutibilidade no Brasil. Revista Brasileira de Atividade Física e Saúde 2001;6:5-18.
21. Crocker PR, Bailey DA, Faulkner RA, et al. Measuring general levels of physical activity: preliminary evidence for the physical activity questionnaire for older children. Med Sci Sports Exerc 1997;29:1344-9.
22. Subcommittee on the Tenth Edition of the RDAs. Food and Nutrition Board. Commission of Life Sciences. National Research Council. Recommended Dietary Allowances. 10th edn. Washington, DC: National Academy Press, 1989.
23. Centeville M, Morcillo AM, Barros Filho Ade A, et al. Lack of association between nutritional status and change in clinical category among HIV-infected children in Brazil. Sao Paulo Med J 2005;23:62-6.
24. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 2004;18:1443-51.
25. Guillén S, Ramos JT, Resino R, et al. Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J 2007;26:334-8.
26. Aurpibul L, Puthanakit T, Taecharoenkul S, et al. Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. AIDS Patient Care STDs 2009;23:1067-71.
27. Shet A, Mehta S, Rajagopalan N, et al. Anemia and growth failure among HIV-infected children in India: a retrospective analysis. BMC Pediatr 2009;16:37-45.
28. Bobat R, Coovadia H, Moodley D, et al. Growth in early childhood in a cohort of children born to HIV-1 infected women from Durban, South Africa. Ann Trop Paediatr 2001;21:203-10.
29. Chantry CJ, Frederick MM, Meyer WA, et al. Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2007;26:53-60.
30. Arpadi SM, Bethelb J, Horlicka M, et al. Longitudinal changes in regional fat content in HIV-infected children and adolescents. AIDS 2009;23:1501-9.
31. Buonora S, Nogueira S, Pone MV, et al. Growth parameters in HIV-vertically-infected adolescents on antiretroviral therapy in Rio de Janeiro, Brazil. Ann Trop Paediatr 2008;28:59-64.
32. Kruzich LA, Marquis GS, Wilson CM, Stephensen CB. HIV-infected US youth are at high risk of obesity and poor diet quality: a challenge for improving short- and long-term health outcomes. J Am Diet Assoc 2004;104:1554-60.
33. Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS 2008;22:925-30.
34. Aurpibul L, Puthanakit T, Lee B, et al. Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Antivir Ther 2007;12:1247-54.
35. Das S. Risk of cardiovascular disease in HIV-infected patients. J Antimicrob Chemother 2010;65:386-9.
36. Sacher PM, Kolotourou M, Chadwick PM, et al. Randomized controlled trial of the MEND program: a family-based community intervention for childhood obesity. Obesity 2010;18:62-8